Levobunolol Hydrochloride is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Levobunolol Hydrochloride.
| Product ID | 24208-505_13f92521-4b0a-4f52-8eaa-836c518098b1 |
| NDC | 24208-505 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levobunolol Hydrochloride |
| Generic Name | Levobunolol Hydrochloride |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1994-03-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074326 |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LEVOBUNOLOL HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1994-03-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074326 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1994-03-04 |
| Marketing Category | ANDA |
| Application Number | ANDA074326 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1994-03-04 |
| Marketing Category | ANDA |
| Application Number | ANDA074326 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1994-03-04 |
| Ingredient | Strength |
|---|---|
| LEVOBUNOLOL HYDROCHLORIDE | 5 mg/mL |
| SPL SET ID: | 5ab1efbe-530b-4787-b40a-c7dbf18161e1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24208-505 | Levobunolol Hydrochloride | Levobunolol Hydrochloride |
| 60758-060 | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride |
| 60758-063 | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride |
| 0023-4385 | BETAGAN | levobunolol hydrochloride |